Cargando…
Addition of an induction regimen of antiangiogenesis and antitumor immunity to standard chemotherapy improves survival in advanced malignancies
Studies have shown that cancer requires two conditions for tumor progression: cancer cell proliferation and an environment permissive to and conditioned by malignancy. Chemotherapy aims to control the number and proliferation of cancer cells, but it does not effectively control the two best-known co...
Autores principales: | Lasalvia-Prisco, Eduardo, Goldschmidt, Pablo, Galmarini, Felipe, Cucchi, Silvia, Vázquez, Jesús, Aghazarian, Martha, Lasalvia-Galante, Eduardo, Golomar, Wilson, Gordon, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505507/ https://www.ncbi.nlm.nih.gov/pubmed/22810591 http://dx.doi.org/10.1007/s12032-012-0301-1 |
Ejemplares similares
-
Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer
por: Lasalvia-Prisco, Eduardo, et al.
Publicado: (2008) -
Advanced ovarian cancer: Vaccination site draining lymph node as target of immuno-modulative adjuvants in autologous cancer vaccine
por: Lasalvia-Prisco, Eduardo, et al.
Publicado: (2007) -
‘Mate’ Intake, Hormone-Based Risk Factors and Breast Cancer: a Case-Control Study
por: Ronco, Alvaro L, et al.
Publicado: (2017) -
Monitoring antiangiogenesis of bevacizumab in zebrafish
por: Zhang, Jing, et al.
Publicado: (2018) -
Cyclin G2 in macrophages triggers CTL-mediated antitumor immunity and antiangiogenesis via interferon-gamma
por: Liu, Lu, et al.
Publicado: (2022)